Test bank for Tietz Fundamentals of Clinical Chemistry
and Molecular Diagnostics,
8th Edition by Nader Rifai, PhD
Chapters 1 - 49
,Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics 8th Edition Test Bank
Table of contents:
I. Principles Of Laboratory Medicine
Chapter 1. Clinical Chemistry, Molecular Diagnostics, and Laboratory Medicine
Chapter 2. Selection and Analytical Evaluation of Methods — With Statistical Techniques
Chapter 3. Clinical Evaluation of Methods
Chapter 4. Evidence-Based Laboratory Medicine
Chapter 5. Establishment and Use of Reference Values
Chapter 6. Specimen Collection, Processing, and Other Preanalytical Variables
Chapter 7. Quality Management
II. Analytical Techniques And Instrumentation
Chapter 8. Principles of Basic Techniques and Laboratory Safety
Chapter 9. Optical Techniques
Chapter 10. Electrochemistry and Chemical Sensors
Chapter 11. Electrophoresis
Chapter 12. Chromatography
Chapter 13. Mass Spectrometry
Chapter 14. Enzyme and Rate Analyses
Chapter 15. Immunochemical Techniques
Chapter 16 Automation
Chapter 17. Point-of-Care Instrumentation
III. Analytes
Chapter 18. Amino Acids, Peptides, and Proteins
Chapter 19. Serum Enzymes
Chapter 20. Tumor Markers and Cancer Genes
Chapter 21. Kidney Function Tests — Creatinine, GFR, Urea, and Uric Acid
Chapter 22. Carbohydrates
Chapter 23. Lipids, Lipoproteins, Apolipoproteins, and Other Cardiac Risk Factors
Chapter 24. Electrolytes and Blood Gases
Chapter 25. Hormones
Chapter 26. Catecholamines and Serotonin
Chapter 27. Vitamins, Trace Elements, Nutritional Assessment
Chapter 28. Hemoglobin, Iron, and Bilirubin
Chapter 29. Porphyrins and Porphyrias
Chapter 30. Therapeutic Drugs and Their Management
Chapter 31. Clinical Toxicology
Chapter 32. Toxic Metals
IV. Pathophysiology
Chapter 33. Diabetes
,Chapter 34. Cardiovascular Disease
Chapter 35. Kidney Disease
Chapter 36. Physiology and Disorders of Water, Electrolyte, and Acid-Base Metabolism
Chapter 37. Liver Disease
Chapter 38. Gastrointestinal and Pancreatic Diseases
Chapter 39. Disorders of Bone and Mineral Metabolism
Chapter 40. Disorders of the Pituitary Gland
Chapter 41. Disorders of the Adrenal Cortex
Chapter 42. Thyroid Disorders
Chapter 43. Reproduction-Related Disorders
Chapter 44. Pregnancy and Prenatal Testing
Chapter 45. Newborn Screening and Inborn Errors of Metabolism
Chapter 46. Pharmacogenetics
V. Molecular Diagnostics
Chapter 47. Principles of Molecular Biology
Chapter 48. Nucleic Acid Techniques and Applications
Chapter 49. Genomes and Nucleic Acid Alterations
, Chapter 01: Clinical Chemistry, Molecular Diagnostics, and Laboratory Medicine Test
Bank
MULTIPLE CHOICE
1. An individual working in a clinical chemistry laboratory is married to a sales representative
who works for a company that sells chemistry laboratory supplies. When the laboratory
manager requests a list of needed supplies, cost of supplies, and vendors, this individual
onlyrecommends the spouse’s company as the vendor. This is considered to be a(n):
a. accounting issue.
b. possible conflict of interest.
c. maintenance of confidentiality issue.
d. problem with resource allocation.
ANS: B
Concern has been raised over the interrelationships between practitioners in the medical
fieldand commercial suppliers of drugs, devices, equipment, etc., to the medical profession.
Similarly, relationships have been scrutinized between clinical laboratorians and
manufacturers and providers of diagnostic equipment and supplies. These concerns led the
National Institutes of Health (NIH) in 1995 to require official institutional review of financial
disclosure by researchers and management of situations in which disclosure indicates
potentialconflicts of interest.
DIF: 1 REF: Page 4-5 OBJ: 6 | 7
2. A jpatient jvisits jher jphysician jstating jthat jher jprescribed jpainkiller jis jnot jworking jto
jreduce jthe jpain jfollowing jher jrecent jsurgery. jA jfriend jof jthe jpatient jclaims jthat jthe
jsame jpainkillerj“worked jwonders” jto jreduce jher jpain jafter jthe jsame jsurgery. jThe
jphysician jstates jthat jthe jdifference jin jthe jeffect jof jthe jdrug jmight jbe jcaused jby ,
jwhich jis jstudied jin jpharmacogenetics.
a. epidemiology
b. an jinherited jdisease
c. a jconflict jof jinterest
d. a jgenetic jvariation jin jdrug-metabolizing jenzymes
ANS: j D
Pharmacogenetics jis jthe jstudy jof jthe jgenetic jvariation jof jdrug jmetabolism
jbetweenjindividuals.
DIF: 1 REF: j j jPage j3 OBJ: j 1
3. John jworks jin ja jmolecular jdiagnostics jlaboratory jand jreceives ja jblood jsample jthat jhas
jthe jname jof ja jclose jfriend jprinted jon jthe jbar-coded jlabel. jThe jgenetic jtest jthat jis
jordered jon jthejfriend’s jsample jwould jprovide jdiagnostic jinformation jabout ja jdisorder
jthat jhas ja jpoor jprognosis, jand jthe jtest jis jusually jperformed jby jJohn. jHe jasks ja jfellow
jemployee jto janalyzejthe jsample jfor jhim jand jnot jdivulge jthe jresults. jThis jethical jissue
jconcerns:
a. confidentiality jof jpatient jgenetic jand jmedical jinformation.
b. a jconflict jof jinterest.
c. resource jallocation.
d. diagnostic jaccuracy.
and Molecular Diagnostics,
8th Edition by Nader Rifai, PhD
Chapters 1 - 49
,Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics 8th Edition Test Bank
Table of contents:
I. Principles Of Laboratory Medicine
Chapter 1. Clinical Chemistry, Molecular Diagnostics, and Laboratory Medicine
Chapter 2. Selection and Analytical Evaluation of Methods — With Statistical Techniques
Chapter 3. Clinical Evaluation of Methods
Chapter 4. Evidence-Based Laboratory Medicine
Chapter 5. Establishment and Use of Reference Values
Chapter 6. Specimen Collection, Processing, and Other Preanalytical Variables
Chapter 7. Quality Management
II. Analytical Techniques And Instrumentation
Chapter 8. Principles of Basic Techniques and Laboratory Safety
Chapter 9. Optical Techniques
Chapter 10. Electrochemistry and Chemical Sensors
Chapter 11. Electrophoresis
Chapter 12. Chromatography
Chapter 13. Mass Spectrometry
Chapter 14. Enzyme and Rate Analyses
Chapter 15. Immunochemical Techniques
Chapter 16 Automation
Chapter 17. Point-of-Care Instrumentation
III. Analytes
Chapter 18. Amino Acids, Peptides, and Proteins
Chapter 19. Serum Enzymes
Chapter 20. Tumor Markers and Cancer Genes
Chapter 21. Kidney Function Tests — Creatinine, GFR, Urea, and Uric Acid
Chapter 22. Carbohydrates
Chapter 23. Lipids, Lipoproteins, Apolipoproteins, and Other Cardiac Risk Factors
Chapter 24. Electrolytes and Blood Gases
Chapter 25. Hormones
Chapter 26. Catecholamines and Serotonin
Chapter 27. Vitamins, Trace Elements, Nutritional Assessment
Chapter 28. Hemoglobin, Iron, and Bilirubin
Chapter 29. Porphyrins and Porphyrias
Chapter 30. Therapeutic Drugs and Their Management
Chapter 31. Clinical Toxicology
Chapter 32. Toxic Metals
IV. Pathophysiology
Chapter 33. Diabetes
,Chapter 34. Cardiovascular Disease
Chapter 35. Kidney Disease
Chapter 36. Physiology and Disorders of Water, Electrolyte, and Acid-Base Metabolism
Chapter 37. Liver Disease
Chapter 38. Gastrointestinal and Pancreatic Diseases
Chapter 39. Disorders of Bone and Mineral Metabolism
Chapter 40. Disorders of the Pituitary Gland
Chapter 41. Disorders of the Adrenal Cortex
Chapter 42. Thyroid Disorders
Chapter 43. Reproduction-Related Disorders
Chapter 44. Pregnancy and Prenatal Testing
Chapter 45. Newborn Screening and Inborn Errors of Metabolism
Chapter 46. Pharmacogenetics
V. Molecular Diagnostics
Chapter 47. Principles of Molecular Biology
Chapter 48. Nucleic Acid Techniques and Applications
Chapter 49. Genomes and Nucleic Acid Alterations
, Chapter 01: Clinical Chemistry, Molecular Diagnostics, and Laboratory Medicine Test
Bank
MULTIPLE CHOICE
1. An individual working in a clinical chemistry laboratory is married to a sales representative
who works for a company that sells chemistry laboratory supplies. When the laboratory
manager requests a list of needed supplies, cost of supplies, and vendors, this individual
onlyrecommends the spouse’s company as the vendor. This is considered to be a(n):
a. accounting issue.
b. possible conflict of interest.
c. maintenance of confidentiality issue.
d. problem with resource allocation.
ANS: B
Concern has been raised over the interrelationships between practitioners in the medical
fieldand commercial suppliers of drugs, devices, equipment, etc., to the medical profession.
Similarly, relationships have been scrutinized between clinical laboratorians and
manufacturers and providers of diagnostic equipment and supplies. These concerns led the
National Institutes of Health (NIH) in 1995 to require official institutional review of financial
disclosure by researchers and management of situations in which disclosure indicates
potentialconflicts of interest.
DIF: 1 REF: Page 4-5 OBJ: 6 | 7
2. A jpatient jvisits jher jphysician jstating jthat jher jprescribed jpainkiller jis jnot jworking jto
jreduce jthe jpain jfollowing jher jrecent jsurgery. jA jfriend jof jthe jpatient jclaims jthat jthe
jsame jpainkillerj“worked jwonders” jto jreduce jher jpain jafter jthe jsame jsurgery. jThe
jphysician jstates jthat jthe jdifference jin jthe jeffect jof jthe jdrug jmight jbe jcaused jby ,
jwhich jis jstudied jin jpharmacogenetics.
a. epidemiology
b. an jinherited jdisease
c. a jconflict jof jinterest
d. a jgenetic jvariation jin jdrug-metabolizing jenzymes
ANS: j D
Pharmacogenetics jis jthe jstudy jof jthe jgenetic jvariation jof jdrug jmetabolism
jbetweenjindividuals.
DIF: 1 REF: j j jPage j3 OBJ: j 1
3. John jworks jin ja jmolecular jdiagnostics jlaboratory jand jreceives ja jblood jsample jthat jhas
jthe jname jof ja jclose jfriend jprinted jon jthe jbar-coded jlabel. jThe jgenetic jtest jthat jis
jordered jon jthejfriend’s jsample jwould jprovide jdiagnostic jinformation jabout ja jdisorder
jthat jhas ja jpoor jprognosis, jand jthe jtest jis jusually jperformed jby jJohn. jHe jasks ja jfellow
jemployee jto janalyzejthe jsample jfor jhim jand jnot jdivulge jthe jresults. jThis jethical jissue
jconcerns:
a. confidentiality jof jpatient jgenetic jand jmedical jinformation.
b. a jconflict jof jinterest.
c. resource jallocation.
d. diagnostic jaccuracy.
